Modeling the within-host dynamics of Plasmodium vivax hypnozoite activation: An analysis of the SPf66 vaccine trial.
Mehra S. et al, (2024), Proc Natl Acad Sci U S A, 121
Methaemoglobin as a surrogate marker of primaquine antihypnozoite activity in Plasmodium vivax malaria: A systematic review and individual patient data meta-analysis
Fadilah I. et al, (2024), PLOS Medicine, 21, e1004411 - e1004411
Evaluation of hydroxychloroquine or chloroquine for the prevention of COVID-19 (COPCOV): A double-blind, randomised, placebo-controlled trial.
Schilling WHK. et al, (2024), PLoS medicine, 21
Temporal changes in SARS-CoV-2 clearance kinetics and the optimal design of antiviral pharmacodynamic studies: an individual patient data meta-analysis of a randomised, controlled, adaptive platform study (PLATCOV)
Wongnak P. et al, (2024), The Lancet Infectious Diseases, 24, 953 - 963
Lineage-informative microhaplotypes for recurrence classification and spatio-temporal surveillance of Plasmodium vivax malaria parasites
Siegel SV. et al, (2024), Nature Communications, 15
Transmission-blocking activities of artesunate, chloroquine, and methylene blue on Plasmodium vivax gametocytes.
Chaumeau V. et al, (2024), Antimicrobial agents and chemotherapy
Phase 2 pilot trial to optimise pharmacometric evaluations in Chagas disease (CHARM: CHAgas disease PharMacometrics)
Cruz CV. et al, (2024), Wellcome Open Research, 9, 342 - 342
The relationship between viral clearance rates and disease progression in early symptomatic COVID-19: a systematic review and meta-regression analysis
Singh S. et al, (2024), Journal of Antimicrobial Chemotherapy, 79, 935 - 945
Comparison of WHO versus national COVID-19 therapeutic guidelines across the world: not exactly a perfect match
Cokljat M. et al, (2024), BMJ Global Health, 9, e014188 - e014188
Spatial Analysis of Drug-Susceptible and Multidrug-Resistant Cases of Tuberculosis, Ho Chi Minh City, Vietnam, 2020-2023.
Spies R. et al, (2024), Emerging infectious diseases, 30, 499 - 509
Where will rectal artesunate suppositories save lives?
Watson JA. et al, (2024), The Lancet, 403, 1137 - 1138
Primaquine in glucose-6-phosphate dehydrogenase deficiency: an adaptive pharmacometric assessment of ascending dose regimens in healthy volunteers
Pukrittayakamee S. et al, (2024), eLife, 12
Effect of primaquine dose on the risk of recurrence in patients with uncomplicated Plasmodium vivax: a systematic review and individual patient data meta-analysis
Commons RJ. et al, (2024), The Lancet Infectious Diseases, 24, 172 - 183
Primaquine dose and the risk of haemolysis in patients with uncomplicated Plasmodium vivax malaria: a systematic review and individual patient data meta-analysis
Rajasekhar M. et al, (2024), The Lancet Infectious Diseases, 24, 184 - 195
Clinical antiviral efficacy of favipiravir in early COVID-19 (PLATCOV): an open-label, randomised, controlled, adaptive platform trial
Luvira V. et al, (2024), BMC Infectious Diseases, 24